Switzerland ‘unfortunately’ still awaiting AstraZeneca COVID-19 vaccine data - official

  • 📰 Reuters
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Switzerland's drug regulator is still awaiting data needed to consider whether to approve AstraZeneca's (AZN.L) COVID-19 vaccine, a Swissmedic official said on Tuesday, adding the information 'unfortunately' had yet to be submitted.

Claus Bolte, Swissmedic’s head of approvals, said AstraZeneca’s approval process had dragged on as part of a “curious” situation, marked by the company’s release ofin March that drew U.S. officials’ rebuke, before days later issuing slightly worse numbers.

"We're waiting, just like the U.S. Food and Drug Administration, for the results of clinical trials in Latin America and North America," Bolte said during a press conference from Bern. "It was announced four weeks ago, but it has unfortunately not yet been submitted," he said. "We want to decide on an approval. Right now, however, it's not possible."

With AstraZeneca’s vaccine associated with very rare blood clots in Europe, Bolte added Switzerland could eventually make recommendations on limits aboutAstraZeneca did not immediately respond to an emailed request for comment. The European Medicines Agency said earlier this month theAlso at the press conference, Swiss vaccines czar Nora Kronig said Moderna's COVID-19 vaccine deliveries had experienced some hiccups and delays, but the government still anticipated the U.S.

Switzerland expects eight million doses combined from Moderna and Pfizer and its German partner BionTech

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca says U.S. data load for U.S. COVID-19 vaccine approval very bigAstraZeneca (AZN.L) is working as fast as possible to compile data on its COVID-19 vaccine to apply for U.S. approval but the dataset is very big, executives said on Friday as the drugmaker faces delays to its submission.
Source: Reuters - 🏆 2. / 97 Read more »

Port Canaveral becomes first U.S. port to begin distributing vaccines for workers, crew membersPort Canaveral in Florida became the first port to start distributing COVID-19 vaccines, officials announced. nuts... Comment ça va ce passer pour aller en Floride ? About bloody time
Source: FoxNews - 🏆 9. / 87 Read more »

Swedes under 65 to be given alternative to AstraZeneca vaccine for second doseSwedes under 65 vaccinated with one shot of the AstraZeneca COVID-19 vaccine will be given a different vaccine for the second dose, the Swedish Health Agency said on Tuesday. It's like Sweden is modeling for the rest of the world things that should not be done, so everyone learns what happens if it's done anyway.
Source: Reuters - 🏆 2. / 97 Read more »

Malaysia receives first batch of AstraZeneca COVID-19 vaccines - BernamaMalaysia received 268,800 doses of AstraZeneca (AZN.L) vaccines on Friday night, its first batch from the pharmaceutical company, state news agency reported on Saturday. Falls flat in the West! sell it in the East.
Source: Reuters - 🏆 2. / 97 Read more »

Health Canada finds Astrazeneca COVID-19 vaccines from Baltimore plant safe, of high qualityCanada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc (AZN.L) COVID-19 vaccine imported from Emergent BioSolutions' (EBS.N) Baltimore facility were safe and met quality specifications.
Source: Reuters - 🏆 2. / 97 Read more »